European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 3.660
0.00 (0.00%)
Oct 26, 2026, 9:00 AM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €15.49 million as of October 26, 2026. It is the 37,879th most valuable company in the world and the 97th biggest in Belgium. Its market cap has decreased by 33.21% in one year.
Market Cap
15.49M
Enterprise Value
31.66M
Revenue
51.36M
Global Rank
Country Rank
#97 Belgium
PE Ratio
8.00
ChartMarket Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 15.49M, a decrease of -82.01%. That is a compound annual growth rate of -15.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 15.49M | -29.62% |
| Dec 31, 2025 | 22.01M | -13.33% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 51.99B |
| argenx SE | 48.92B |
| Financière de Tubize | 9.82B |
| Onward Medical | 143.92M |
| Hyloris Pharmaceuticals | 110.32M |
| Celyad Oncology | 10.03M |
| BioSenic | 1.31M |
| Oxurion NV | 112.59K |